Polysaccharide-Encapsulated Lipid Droplets for Oral Drug Bioavailability

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing delivery systems face challenges in effectively delivering poorly water-soluble active substances, particularly pharmaceutical agents, due to issues such as precipitation in the gastrointestinal tract, absorption barriers, and the inability to penetrate cellular membranes, especially in the presence of biofilms, leading to reduced efficacy and antibiotic resistance.

Innovation Solution

A dry composition comprising lipid droplets encapsulated within polysaccharide walls, specifically inulin or glucomannan, which are not in nano-particulate form, allowing for efficient delivery of active substances, including poorly water-soluble drugs and antimicrobial agents, through a spray-drying process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If poorly water-soluble drugs are administered orally, then the preferred route of administration is achieved, but precipitation occurs in the gastrointestinal tract due to low lipophilic environment, reducing absorption and bioavailability

Engineering Contradiction:

Improveroute of administrationVSAvoidabsorption and bioavailability

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

The patent uses a composite material system consisting of lipid droplets encapsulated within polysaccharide walls (inulin or glucomannan). This composite structure combines the lipophilic nature of lipid droplets to solubilize poorly water-soluble drugs with the hydrophilic polysaccharide matrix that prevents precipitation in the gastrointestinal tract, thereby maintaining both ease of oral administration and reliable drug absorption

Inventive Principle:

Principle #40Composite materials

Solution Approach 2:

The invention changes the physical-chemical parameters of the drug delivery system by transforming poorly water-soluble drugs into a dispersed state within lipid droplets, which are then encapsulated in polysaccharide matrices. This parameter change from crystalline to dispersed state, and from direct contact with GI fluids to encapsulated delivery, resolves the precipitation issue while maintaining oral administration feasibility

Inventive Principle:

Principle #35Parameter changes

2Device complexity

If conventional antibiotics are used to treat intracellular pathogens, then the treatment approach is straightforward, but the antibiotics cannot efficiently penetrate cellular membranes, leading to treatment failure

Engineering Contradiction:

Improvetreatment approachVSAvoidpenetration of cellular membranes

Core Design Contradiction:

Device complexityVSReliability

Solution Approach 1:

The patent changes the delivery parameter of antibiotics by encapsulating them within lipid droplets that are themselves enclosed in polysaccharide walls. This dual-encapsulation system transforms the delivery mechanism from direct antibiotic application to a controlled release system that can penetrate cellular membranes more effectively, enabling treatment of intracellular pathogens while maintaining treatment simplicity

Inventive Principle:

Principle #35Parameter changes

3Quantity of substance

If high doses of antibiotics are prescribed to compensate for low drug concentration at the target site, then the drug concentration issue is addressed, but antibiotic resistance develops

Engineering Contradiction:

Improvedrug concentrationVSAvoidantibiotic resistance

Core Design Contradiction:

Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent introduces lipid droplets encapsulated in polysaccharide walls as an intermediary delivery system. This mediator transports antibiotics to the target site with controlled release, ensuring adequate drug concentration at the infection site without requiring high systemic doses, thereby preventing antibiotic resistance while maintaining effective treatment concentrations

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the concentration delivery parameter by using a targeted release mechanism. Instead of maintaining high concentrations throughout the body, the encapsulated system releases antibiotics locally at the infection site, achieving effective concentration where needed while minimizing overall drug exposure that would drive resistance development

Inventive Principle:

Principle #35Parameter changes

4Quantity of substance

If poorly soluble drugs are solubilised with large amounts of co-solvents and surfactants for parenteral delivery, then solubility is improved, but adverse physiological reactions occur

Engineering Contradiction:

ImprovesolubilityVSAvoidadverse physiological reactions

Core Design Contradiction:

Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent employs a composite material system of lipid droplets within polysaccharide walls that provides solubility enhancement without requiring large amounts of co-solvents or surfactants. The lipid droplet core solubilizes poorly water-soluble drugs while the polysaccharide outer layer ensures compatibility with physiological environments, achieving both solubility improvement and reduced adverse reactions

Inventive Principle:

Principle #40Composite materials

Solution Approach 2:

The encapsulated structure creates a porous interface between the lipophilic core and hydrophilic exterior, allowing controlled interaction with biological fluids. This porous architecture enables drug solubilization while the polysaccharide matrix provides biocompatibility, eliminating the need for harmful co-solvents and surfactants

Inventive Principle:

Principle #31Porous materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition enables effective delivery of active substances to microbial cells and biofilms, enhances gastrointestinal health, and provides therapeutic benefits by improving the bioavailability and stability of drugs, while avoiding biolabile conjugates and maintaining biocompatibility.

Implementation Method 1

lipid droplets encapsulated within polysaccharide walls

Methodology Applied

Scientific EffectEncapsulation:

Implementation Method 2

improving the bioavailability and stability of drugs

Methodology Applied

Scientific EffectSolubility enhancement:

Implementation Method 3

through a spray-drying process

Methodology Applied

Scientific EffectSpray-drying:

Implementation Method 4

enables effective delivery of active substances to microbial cells and biofilms

Methodology Applied

Scientific EffectMembrane penetration:

Implementation Method 5

improving the bioavailability and stability of drugs

Methodology Applied

Scientific EffectBioavailability enhancement:

Data Source

PatentUS20250360087A1Compositions comprising lipid droplets encapsulated within polysaccharide walls and uses thereof

Publication Date: 2025.11.27 UNIV OF SOUTH AUSTRALIA

AI summary

Drug delivery systems are needed to assist in improving the therapeutic characteristics of pharmaceutical agents. Provided is a dry composition, comprising a polysaccharide, such as inulin, and lipid droplets, wherein the lipid droplets are encapsulated within polymeric chains of the polysaccharide, and wherein the polysaccharide is not in a nano-particulate form. The use of such compositions enables efficient delivery of agents, such as poorly-water soluble drugs and antibiotics.